(Press-News.org) Boston, Mass. - The underdeveloped immune systems of newborns don't respond to most vaccines, leaving them at high risk for infections like rotavirus, pertussis (whooping cough) and pneumococcus. Researchers at Boston Children's Hospital have identified a potent compound that activates immune responses in newborns' white blood cells substantially better than anything previously tested, and that could potentially make vaccines effective right at birth.
The ability to immunize babies at birth—rather than two months of age, when most current vaccination series begin—would be a triumph for global health. Worldwide, each year, infections kill more than 2 million infants under 6 months old. In resource-poor countries, birth may be the only time a child has contact with a health care provider.
While newborns lack most aspects of the immune response, researchers led by Ofer Levy, MD, PhD, of the Division of Infectious Disease at Boston Children's have shown that their white blood cells do have one receptor that responds strongly to stimulation, known as Toll-like receptor 8 (TLR 8). In their new work, published March 4 by the online open-access journal PLoS ONE, they tested a panel of synthetic small-molecule compounds that specifically target TLR8, known chemically as benzazepines.
The compounds, provided by VentiRx Pharmaceuticals (Seattle, WA), potently stimulate the human immune system and are in clinical trials in patients with certain cancers.
Tested in Levy's lab, one benzazepine, VTX-294, produced a strong immune response in white blood cells from newborns (taken from cord blood samples) as well as whole blood from adults. It induced robust production of cytokines—chemicals that rally the immune response—and proved at least 10 times more potent than the best activator of TLR8 known previously.
"The response was not only equal to that in adults, but VTX 294 was sometimes actually more effective in newborns than adults," notes Levy, the study's senior investigator.
The compound also triggered production of so-called co-stimulatory molecules that enhance immune responses. Moreover, even very low concentrations of VTX-294 strongly activated antigen-presenting cells, a type of white blood cell whose activation induces immune memory—key to effective responses to vaccines.
Toll-like receptors (TLRs), first identified in humans about two decades ago, are part of the innate (rapid) immune response that provides our first defense against infections. Ten types of TLRs are known, and TLR stimulators have begun to be added to vaccines as adjuvants. The main one, monophosphoryl lipid A (MPLA), stimulates TLR4 and is used in the human papillomavirus vaccine Cervarix. However, in a recent clinical trial published in The New England Journal of Medicine, a malaria vaccine with MPLA failed to elicit a sufficient immune response in infants.
With encouraging results in cells from human newborns, Levy and colleagues now hope to formulate VTX 294 or a similar TLR8 stimulator for testing as a vaccine adjuvant in newborn primates, a model in which the lab has expertise, and whose responses to TLR8 closely resemble humans'.
"This one receptor seems to lead to more adult-like responses—immediate, short-term responses that are more appropriate for fighting infections," says David Dowling, PhD, co-first author on the study. "We're excited about the benzazepines because they are already in the clinical pipeline. That advances the potential for using them in a clinical study in human newborns, once they have been proven safe in animal studies."
### The current study was supported by VentiRx Pharmaceuticals and grants from the National Institutes of Health (R01 18AI100135-01). Dowling and Zhen Tan, MD of the Division of Infectious Diseases at Boston Children's Hospital share first authorship on the paper. Coauthors were Zofia Prokopowicz, PhD, and Christine Palmer, PhD, of Boston Children's, and Maura-Ann Matthews, PhD, Gregory Dietsch, PhD, DABT, and Robert Hershberg, MD, PhD, of VentiRx.
For further background on the Levy lab's work, see this blog post.
Boston Children's Hospital is home to the world's largest research enterprise based at a pediatric medical center, where its discoveries have benefited both children and adults since 1869. More than 1,100 scientists, including nine members of the National Academy of Sciences, 11 members of the Institute of Medicine and 11 members of the Howard Hughes Medical Institute comprise Boston Children's research community. Founded as a 20-bed hospital for children, Boston Children's today is a 395-bed comprehensive center for pediatric and adolescent health care grounded in the values of excellence in patient care and sensitivity to the complex needs and diversity of children and families. Boston Children's also is a teaching affiliate of Harvard Medical School. For more information about research and clinical innovation at Boston Children's, visit: http://vectorblog.org/.
A vaccine that works in newborns?
Promising compound may help protect babies during vulnerable window
2013-03-05
ELSE PRESS RELEASES FROM THIS DATE:
Is baby still breathing? Is mom's obsession normal?
2013-03-05
CHICAGO --- A new mother may constantly worry and check to see if her baby is still breathing. Or she may fret about germs, obsessing whether she's properly sterilized the bottles, then wash and rewash them.
A new Northwestern Medicine® study found that women who have recently given birth have a much higher rate of obsessive-compulsive symptoms than the general population.
The study found 11 percent of women at two weeks and six months postpartum experience significant obsessive-compulsive symptoms compared to 2 to 3 percent in the general population. This is the ...
HIV infection appears associated with increased heart attack risk
2013-03-05
A study that analyzed data from more than 82,000 veterans suggests that infection with the human immunodeficiency virus (HIV) was associated with an increased risk of acute myocardial infarction (AMI, heart attack) beyond what is explained by recognized risk factors, according to a report published Online First by JAMA Internal Medicine, a JAMA Network publication.
Due to the successful antiretroviral therapy (ART), people infected with HIV are living longer and are at risk for heart disease, authors wrote in the study background.
Matthew S. Freiberg, M.D., M.Sc., of ...
Parkinson's disease brain rhythms detected
2013-03-05
A team of scientists and clinicians at UC San Francisco has discovered how to detect abnormal brain rhythms associated with Parkinson's by implanting electrodes within the brains of people with the disease.
The work may lead to developing the next generation of brain stimulation devices to alleviate symptoms for people with the disease.
Described this week in the journal Proceedings of the National Academy of Sciences (PNAS), the work sheds light on how Parkinson's disease affects the brain, and is the first time anyone has been able to measure a quantitative signal ...
Mom's placenta reflects her exposure to stress and impacts offsprings' brains, Penn Vet team finds
2013-03-05
PHILADELPHIA — The mammalian placenta is more than just a filter through which nutrition and oxygen are passed from a mother to her unborn child. According to a new study by a research group from the University of Pennsylvania School of Veterinary Medicine, if a mother is exposed to stress during pregnancy, her placenta translates that experience to her fetus by altering levels of a protein that affects the developing brains of male and female offspring differently.
These findings suggest one way in which maternal-stress exposure may be linked to neurodevelopmental diseases ...
New data show countries around the world grappling with changing health challenges
2013-03-05
SEATTLE – Alzheimer's disease is the fastest growing threat to health in the US. HIV/AIDS and alcohol are severely eroding the health of Russians. Violence is claiming the lives of young men in large swaths of Latin America, constituting a homicide-driven health crisis. Despite health gains in sub-Saharan Africa, infectious diseases still cause hundreds of thousands of child deaths.
These are just some of the new findings from the Global Burden of Diseases, Injuries, and Risk Factors 2010 Study (GBD 2010), a systemic, scientific effort to quantify the comparative magnitude ...
New Lancet paper reveals that UK lags behind much of Europe on key measures of health
2013-03-05
SEATTLE – Britons are living longer lives and enjoying better health, but they are still grappling with disabling conditions such as back and neck pain and depression, often more than people in most other European countries. Health in the United Kingdom is eroded by preventable causes of death such as smoking, unhealthy diets, and use of alcohol and drugs. As a result, the UK's pace of decline in premature mortality has fallen well behind the average of 14 other original members of the European Union, Australia, Canada, Norway, and the United States (EU15+) over the past ...
The right dose for oncology
2013-03-05
King Mithridates understood that poison is only as good as the dosage taken. Each day, he ingested small quantities of poison in order to become immunize and escape his court's plotters. Oncologists run up against the same principle when fighting cancer. Sometimes, a small dose of chemotherapy may induce dangerous resistance mechanisms in malignant cells, resulting in relapse. Now, EPFL research published in the journal PLOS ONE reports a tool that could simply and accurately determine the right dose for individual patients.
Dosage, a vital issue
This novel tool, developed ...
Pharmaceutical advertising down but not out
2013-03-05
The pharmaceutical industry has pulled back on marketing to physicians and consumers, yet some enduring patterns persist. According to a new study led by researchers at the Johns Hopkins Bloomberg School of Public Health, advertising peaked in 2004, with industry promotion to physicians declining nearly 25 percent by 2010, to $27.7 billion or 9 percent of sales. Similar declines were seen in direct-to-consumer advertising, which remains concentrated among a small number of products. The number of products promoted to providers peaked at over 3,000 in 2004, and declined ...
Accurate water vapor measurements for improved weather and climate models
2013-03-05
Humidity measurements in the atmosphere are of essential importance, since water vapour, as the most important natural greenhouse gas, has a strong influence on the Earth's atmospheric radiation balance and, thus, decisively influences our climate. In addition, water is responsible for meteorological phenomena such as the formation of clouds and precipitation. Hence, the atmospheric water content is an essential measurand in all climate models, but also when it comes to forecasting the weather; this measurand has to be determined with great accuracy if reliable predictions ...
Quality of care measures improve performance
2013-03-05
Public reporting of how physicians and hospitals perform in quality of care measures leads to improved care for patients. A collaborative team of researchers led by Geoffrey C. Lamb, M.D., professor of internal medicine at the Medical College of Wisconsin, published their findings in the March 2013 edition of Health Affairs.
The researchers analyzed 14 publicly reported quality of care measures from 2004 to 2009 for the Wisconsin Collaborative for Healthcare Quality, a voluntary consortium of physician groups, and found that physician groups in the collaborative improved ...
LAST 30 PRESS RELEASES:
Scientists target ‘molecular machine’ in the war against antimicrobial resistance
Extending classical CNOP method for deep-learning atmospheric and oceanic forecasting
Aston University research: Parents should encourage structure and independence around food to support children’s healthy eating
Thunderstorms are a major driver of tree death in tropical forests
Danforth Plant Science Center adds two new faculty members
Robotic eyes mimic human vision for superfast response to extreme lighting
Racial inequities and access to COVID-19 treatment
Residential segregation and lung cancer risk in African American adults
Scientists wipe out aggressive brain cancer tumors by targeting cellular ‘motors’
Capturability distinction analysis of continuous and pulsed guidance laws
CHEST expands Bridging Specialties Initiative to include NTM disease and bronchiectasis on World Bronchiectasis Day
Exposure to air pollution may cause heart damage
SwRI, UTSA selected by NASA to test electrolyzer technology aboard parabolic flight
Prebiotics might be a factor in preventing or treating issues caused by low brain GABA
Youngest in class at higher risk of mental health problems
American Heart Association announces new volunteer leaders for 2025-26
Gut microbiota analysis can help catch gestational diabetes
FAU’s Paulina DeVito awarded prestigious NSF Graduate Research Fellowship
Champions for change – Paid time off initiative just made clinical trials participation easier
Fentanyl detection through packaging
Prof. Eran Meshorer elected to EMBO for pioneering work in epigenetics
New 3D glacier visualizations provide insights into a hotter Earth
Creativity across disciplines
Consequences of low Antarctic sea ice
Hear here: How loudness and acoustic cues help us judge where a speaker is facing
A unique method of rare-earth recycling can strengthen the raw material independence of Europe and America
Epilepsy self-management program shows promise to control seizures, improve mood and quality of life
Fat may play an important role in brain metabolism
New study finds no lasting impact of pandemic pet ownership on human well-being
New insights on genetic damage of some chemotherapies could guide future treatments with less harmful side effects
[Press-News.org] A vaccine that works in newborns?Promising compound may help protect babies during vulnerable window